Myocardial infarction in the elderly. Clinical and therapeutic differences
Anna Polewczyk1, Marianna Janion, Mariusz Gasior
1Swietokrzyskie Cardiology Center, District Hospital, Kielce, Poland. annapolewczyk@wp.pl
Kardiologia Polska
|March 18, 2008
Summary
Elderly patients with acute myocardial infarction (MI) face higher mortality due to risk factors and less invasive treatment. Implementing invasive strategies significantly reduces mortality in this population.
Area of Science:
- Cardiology
- Geriatric Medicine
- Public Health
Background:
- Aging populations lead to more myocardial infarctions (MI) in older adults.
- Despite treatment advances, elderly MI patients require specific analysis of clinical course and prognosis.
Purpose of the Study:
- Compare clinical characteristics and treatment of MI in patients under 65 versus those 65 and older.
- Evaluate outcomes and identify disparities in MI care for the elderly.
Main Methods:
- Retrospective analysis of 491 patients over 65 and 398 patients under 65 with acute MI.
- Data collected between June 2005 and February 2006.
Main Results:
- Older patients (over 65) had higher rates of hypertension, diabetes, lower ejection fraction, and advanced heart failure.
- The elderly group experienced longer symptom-to-admission times, lower reperfusion therapy rates, and poorer invasive treatment outcomes.
- In-hospital and long-term mortality were significantly higher in the elderly, but lowest among those receiving invasive strategies.
Conclusions:
- Baseline risk factors and reduced invasive therapy contribute to worse prognosis for elderly MI patients.
- Wider implementation of invasive approaches in the elderly is recommended to significantly reduce mortality.
Related Concept Videos
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
01:27Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...